Autoimmune Myocarditis might Reason for the Sudden Death Reports following SARS CoV-2 mRNA vaccination: Could NSAIDs Ameliorate the Risk?

Résumé

This preprint has been published: https://juniperpublishers.com/ijoprs/IJOPRS.MS.ID.555658.php The public has a constitutional right to know all potential hazards of COVID-19 newly approved vaccines to freely decide whether to receive any. We discuss the potential autoimmune risk that is associated with mRNA-based vaccines, the potential role of non-steroidal anti-inflammatory drugs to ameliorate it and discuss some of the newly reported post vaccination cases who encountered serious adverse effects including sudden death. Importantly, we recommend CDC to change its neutral recommendation and to advice against administration of nucleic acid-based vaccines to persons complaining from autoimmune diseases. Furthermore, we urge the FDA to consider a reevaluation of the emergency approval granted to Pfizer-BioNTech SARS CoV-2 mRNA vaccine associated with most of the reported serious adverse effects and fatalities as we suggest that there is a likelihood for at least short-term potential hazard that might be a company specific, to be fully compared it to its Moderna’s counterpart vaccine as regards to its used mRNA sequence and adjuvants.

Citer ce document

Accès au document

Ce document est hébergé sur son dépôt institutionnel d'origine.

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0